Grant: CIHR Fellowship
Direct Payment
$50,000.00
Allosteric Activation of EGFR by Transmembrane - Juxtamembrane Domain and C- Tail
FY 2010-11
Summary
The epidermal growth factor receptor (EGFR) is a transmembrane glycoprotein that is essential for transmitting signals across the cellular membrane. EGFR is involved in signalling pathways involved in cell growth, differentiation, migration and apoptosis, and it represent one of the most promising drug target for the development of new chemotherapeutics. Several cancer therapeutics that target EGFR or its homologs are currently in clinical use. EGFR is comprised of an extracellular ligand binding domain, a transmembrane (TM) domain, a short intracellular juxtamembrane (JM) region, and a tyrosine kinase domain flanked by a C-terminal regulatory region. Each domain plays an important role in the allosteric activation of the kinase domain. Binding of EGF to the ectodomain induces dimerization of the receptor, which allosterically activates the tyrosine kinase domain. This causes the phosphorylation of tyrosine residues at the C-terminal tail, which in turn triggers downstream signalling cascades. However, the role of the TM domain and the C-terminal tail in allosteric activation of EGFR kinase domain is not completely understood. Therefore, in the current proposal, we intend to solve the crystal structure of TM-EGFR and biochemically characterize the role of the C-terminal tail in kinase activation. This study will not only contribute towards the mechanistic understanding of EGFR activation, but will also define a general paradigm for how extracellular signals are transmitted across the membrane. Ultimately, the proposed research is likely to have long-term implications in the field of cancer research.
Department
Program
CIHR Fellowship
Recipient
Location
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
226115
Name
Das Rahul
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Allosteric Activation of EGFR by Transmembrane - Juxtamembrane Domain and C- Tail
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$50,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Biochemistry; Cancer; Cell Signaling; Structural Biology
Abstract
The epidermal growth factor receptor (EGFR) is a transmembrane glycoprotein that is essential for transmitting signals across the cellular membrane. EGFR is involved in signalling pathways involved in cell growth, differentiation, migration and apoptosis, and it represent one of the most promising drug target for the development of new chemotherapeutics. Several cancer therapeutics that target EGFR or its homologs are currently in clinical use. EGFR is comprised of an extracellular ligand binding domain, a transmembrane (TM) domain, a short intracellular juxtamembrane (JM) region, and a tyrosine kinase domain flanked by a C-terminal regulatory region. Each domain plays an important role in the allosteric activation of the kinase domain. Binding of EGF to the ectodomain induces dimerization of the receptor, which allosterically activates the tyrosine kinase domain. This causes the phosphorylation of tyrosine residues at the C-terminal tail, which in turn triggers downstream signalling cascades. However, the role of the TM domain and the C-terminal tail in allosteric activation of EGFR kinase domain is not completely understood. Therefore, in the current proposal, we intend to solve the crystal structure of TM-EGFR and biochemically characterize the role of the C-terminal tail in kinase activation. This study will not only contribute towards the mechanistic understanding of EGFR activation, but will also define a general paradigm for how extracellular signals are transmitted across the membrane. Ultimately, the proposed research is likely to have long-term implications in the field of cancer research.
Competitiondate
201102
Approvedterm2
1 yr 0 mth
Pinamesdelim
Das, Rahul
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $50,000~ $0~